Published February 15, 2008 | Version v1
Journal article

Vesicle-associated membrane protein 7 (VAMP-7) is essential for target cell killing in a natural killer cell line

  • 1. Pulmonary Research Group, Department of Medicine, University of Alberta, 550A Heritage Medical Research Centre, Edmonton, Alta., T6G 2S2 (Canada)
  • 2. Department of Biochemistry, University of Alberta, Edmonton, Alta., T6G 2S2 (Canada)
  • 3. Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alta., T6G 2S2 (Canada)

Description

Natural killer cells recognize and induce apoptosis in foreign, transformed or virus-infected cells through the release of perforin and granzymes from secretory lysosomes. Clinically, NK-cell mediated killing is a major limitation to successful allo- and xenotransplantation. The molecular mechanisms that regulate the fusion of granzyme B-containing secretory lysosomes to the plasma membrane in activated NK cells, prior to target cell killing, are not fully understood. Using the NK cell line YT-Indy as a model, we have investigated the expression of SNAP REceptors (SNAREs), both target (t-) and vesicular (v-) SNAREs, and their function in granzyme B-mediated target cell killing. Our data showed that YT-Indy cells express VAMP-7 and SNAP-23, but not VAMP-2. VAMP-7 was associated with granzyme B-containing lysosomal granules. Using VAMP-7 small interfering RNA (siRNA), we successfully knocked down the expression of VAMP-7 protein in YT-Indy to less than 10% of untreated cells in 24 h. VAMP7-deficient YT-Indy cells activated via co-culture with Jurkat cells released <1 ng/mL of granzyme B, compared to 1.5-2.5 μg/mL from controls. Using Jurkat cells as targets, we showed a 7-fold reduction in NK cell-mediated killing by VAMP-7 deficient YT-Indy cells. Our results show that VAMP-7 is a crucial component of granzyme B release and target cell killing in the NK cell line YT-Indy. Thus, targeting VAMP-7 expression specifically with siRNA, following transplantation, may be a viable strategy for preventing NK cell-mediated transplant rejection, in vivo

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2007.11.079

Additional details

Identifiers

DOI
10.1016/j.bbrc.2007.11.079;
PII
S0006-291X(07)02443-6;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
366
Journal Issue
3
Journal Page Range
p. 617-623
ISSN
0006-291X
CODEN
BBRCA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
39062924
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
APOPTOSIS; CELL KILLING; CELL MEMBRANES; IN VIVO; LYSOSOMES; NATURAL KILLER CELLS; RECEPTORS; RNA; TRANSPLANTS; VIRUSES
Descriptors DEC
BIOLOGICAL MATERIALS; BLOOD; BLOOD CELLS; BODY FLUIDS; CELL CONSTITUENTS; LEUKOCYTES; MATERIALS; MEMBRANE PROTEINS; MEMBRANES; MICROORGANISMS; NUCLEIC ACIDS; ORGANIC COMPOUNDS; PARASITES; PROTEINS

Optional Information

Copyright
Copyright (c) 2007 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.